Transformed Lymphoma / DLBCL
1 clinical trials · Condition
◉ Watch Transformed Lymphoma / DLBCL
| Record | Firm | Date |
|---|---|---|
| Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma (NCT02855359) | Seagen Inc. | 2016-08-01 |
Track Transformed Lymphoma / DLBCL automatically
Every clearance here is in the API, with alerts when new ones post.